Abstract
Atrial flutter or tachycardia may coexist with atrial fibrillation [AF] and can be treated with ablation techniques in attempt to reduce the total AF burden. The role of ablation of latent atrial tachyarrhythmias elicited at electrophysiologic study in conjunction with atrial pacing and antiarrhythmic drugs in patients with refractory AF has not been evaluated. We evaluated the efficacy of catheter ablation of electrically induced atrial flutter or atrial tachycardia in improving rhythm control in patients with refractory AF. Methods: Consecutive patients with refractory AF, and spontaneous atrial flutter (Group 1) or without spontaneous atrial flutter (Group 2) underwent programmed stimulation in a baseline drug-free state. All patients had electrically induced atrial flutter or tachycardia. Radiofrequency ablation of the arrhythmia substrate was performed in all patients. Primary endpoints evaluated for patient outcome in both groups included maintenance of rhythm control and freedom from recurrent atrial tachyarrhythmias. Results: Forty-three patients, with a mean age of 66±13 years were studied. Group 1 consisted of 22 patients while Group 2 had 21 patients. Ablation of the tricuspid valve-inferior venacaval isthmus was performed in 41 patients who had common atrial flutter induced at electrophysiologic study. Ablation of other atrial sites was performed in 8 patients with induced atypical flutter and 4 patients with induced atrial tachycardia. Ten of these patients had ablation of more than one arrhythmia. 17 patients (40%) had atrial pacing instituted and 28 patients remained on a class 1/3 antiarrhythmic drug. During a mean follow-up of 26±14 months, 33 patients (82.5%) remained in rhythm control. Actuarial analysis showed 96% of patients in rhythm control at 6 months, 94% at 12 months, and 90% at 24 months. Freedom from symptomatic AF recurrence was 64% at 6 months, 58% at 12 months, and 42% at 24 months. The outcome for both of these endpoints was similar for Group 1 and Group 2 (p = NS). The AF free interval increased significantly from 7±9 days to 172±121 days (p < 0.01) after ablation. This increase was again similar in both the groups. In the 14 patients were who did not receive atrial pacing and who remained on the same class 1/3 antiarrhythmic drug, the AF free interval increased from 18±17 days to 212±102 days (p < 0.01).
Conclusions: We conclude that electrophysiologic studies can elicit latent atrial flutter or tachycardia in patients with refractory AF without spontaneous monomorphic atrial tachyarrhythmias. Catheter ablation of electrically induced atrial flutter or tachycardia either alone, or with atrial pacing and with antiarrhythmic drug may improve rhythm control and reduce AF recurrences. This is similar in patients with and without spontaneous atrial flutter and refractory AF.
Similar content being viewed by others
References
Cox JL, Boineau JP, Richard B, et al. Five year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 1993;56:814–824.
Schwartz JF, Pellersels G, Silvers J, et al. A catheter based curative approach to atrial fibrillation in humans. Circulation 1994;90(Suppl):I–335 (abstract).
Jais P, Haissaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95:572–576.
Phillipon F, Plumb V, Epstein A, et al. The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter. Circulation 1995;92:430–435.
Saoudi N, Atallah G, Kirkman G, et al. Catheter ablation of the atrial myocardium in human type I atrial flutter. Circulation 1990;81:762.
Curtis AB, Sharma AJ, Sorrentino RA, et al. for the PAC-A-TACH investigators. Predictors of atrial fi-brillation in the tachycardia-bradycardia syndrome: results from the pacing and atrial tachycardia trial. J Am Coll Cardiol 1999;33(Suppl);2:127A (abstract).
Oritz J, Niwano S, Abe H, et al. Mapping of conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res 1994;74:882–894.
Nabar A, Rodriguez LM, Timmermans C, Smeets J, Wellens HJJ. Radiofrequency ablation of class 1C atrial flutter in patients with resistant atrial fibrillation. Am J Cardiol 83:785–787.
Prakash A, Krol RB, Saksena S, et al. Induction of monomorphic atrial tachyarrhythmias is common in patients with atrial fibrillation. PACE 2000;23(23): II–735 (abstract).
Huang D, Monahan KM, Zimetbaum P, et al. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:462–469.
Katritis D, Iliodromitis E, Fragakis N, et al. Ablation therapy of type 1 atrial flutter may eradicate paroxysmal atrial fibrillation. Am J Cardiol 1996;78:345–347.
Moskowitz C, Callans D, Schwartzman D, et al. The results of atrial flutter ablation in patients with and without a history of atrial fibrillation. Am J Cardiol 1996;78:93–96.
Prakash A, Delfaut P, Krol RB, Saksena S. Regional right and left atrial activation patterns during singleand dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol 1998;82:1197–1204.
Prakash A, Saksena S, Hill M, et al. Acute effects of dual site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation.JAm Coll Cardiol 1997;29:1007–1014.
Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing. J Am Coll Cardiol 1996;28:687–694.
Gianfranchi L, Brignole M, Menozza C, et al. Progression of permanent atrial fibrillation after dual chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. Am J Cardiol 1998;81: 351–354.
Sakamoto H, Kurabayashi M, Nagai R, Fujii J. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation. Circulation 1997;96:2612–2616.
Gillis AM, Connolly SJ, Lacombe P, et al. Randomized cross over comparison of DDDR versus VDD pacing after AVJ ablation for prevention of AF. The atrial pacing peri-ablation for paroxysmal atrial fibrillation PA(3) study investigators. Circulation 2000;102:736–741.
Granada JF, Humberto JV, Chyou PH, et al. The natural history of atrial flutter in the general population: incidence, risk factors and impact on mortality. Circulation 1999;100(Suppl):I–396.
Swerdlow CD, Schsis W, Djikman G, et al. Deactivation of atrial fibrillation and flutter by a dual chamber implantable cardioverter-defibrillator. Circulation 2000; 101:878–885.
Krol RB, Saksena S, Prakash A, et al. Prospective clinical evaluation of programmed atrial stimulation protocol for induction of sustained atrial fibrillation and flutter. J Intervent Card Electrophysiol 1999:3: 19–25.
Saksena S, Sumar R, Prakash A, et al. Electrophysiologic study aids selection of “hybrid” therapy in patients with refractory atrial fibrillation. Circulation 1999;100(I):I–69 (abstract).
Olgin JE, Kalman JM, Fitzpatrick AP, Lesh MD. Role of atrial endocardial structures as barriers to conduction during human type 1 atrial flutter: activation and entrainment mapping guided by intracardiac echocardiography. Circulation 1995;92:1839–1848.
Olgin J, Kalman J, Lesh M, et al. Conduction barriers in human atrial flutter: correlation of electrophysiology and anatomy. J Cardiovasc Electrophysiol 1996;7:1112–1126.
Konnings KTS, Kirchof CJHJ, et al. High density mapping of electrically induced atrial fibrillation. Circulation 1994;89:1665–1680.
Saksena S, Giorgberidze I, Mehra R, Hill M, Prakash A, Krol RB, Mathew P. Electrophysiology and endocardial mapping of induced atrial fibrillation in patients with spontaneous atrial fibrillation. Am J Cardiol 1999;83:187–193.
Saksena S. Benefits of new catheter mapping technology: fact or fiction? J Int Card Electrophysiol 2000; 4:339–343.
Roithinger F, Karach M, Steiner P, et al. Relationship between atrial fibrillation and typical atrial flutter in humans. Circulation 1997;96:3484–3491.
Prakash A, Saksena S, Krol RB, Philip G. Right and left atrial activation during external direct-current cardioversion shocks delivered for termination of atrial fibrillation in humans. Am J Cardiol 2001;87: 1080–1088.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prakash, A., Saksena, S., Krol, R.B. et al. Catheter Ablation of Inducible Atrial Flutter, in Combination with Atrial Pacing and Antiarrhythmic Drugs (“Hybrid Therapy”) Improves Rhythm Control in Patients with Refractory Atrial Fibrillation. J Interv Card Electrophysiol 6, 165–172 (2002). https://doi.org/10.1023/A:1015319618049
Issue Date:
DOI: https://doi.org/10.1023/A:1015319618049